News Conference News AATS 2023 Beware High-Risk TAVI in Patients With Low-Lying Coronaries Michael O'Riordan May 11, 2023
News Conference News EHRA 2023 EPs Push for More Involvement in TAVI Heart Team Discussions Michael O'Riordan April 21, 2023
News Conference News EHRA 2023 Novel Score Identifies HF Patients With AF Who Respond to Ablation Michael O'Riordan April 19, 2023
News Conference News EHRA 2023 Synchronized LV Pacing Not Superior to Conventional CRT in Heart Failure Michael O'Riordan April 18, 2023
News Conference News EHRA 2023 Outcomes Just as Good With Delayed vs Early AF Ablation Michael O'Riordan April 17, 2023
News Conference News EHRA 2023 Esophageal Fistula Still a Rare but Deadly Complication of AF Ablation: POTTER-AF Michael O'Riordan April 17, 2023
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023
News Conference News THT 2023 High-Intensity Care After Acute HF Pays Off Across LVEF Spectrum: STRONG-HF Todd Neale March 23, 2023
News Conference News THT 2023 Meta-analysis Hints at Survival Benefit With LAP Monitoring in HFrEF Shelley Wood March 22, 2023
News Conference News THT 2023 Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF Todd Neale March 22, 2023
News Conference News THT 2023 Higher Gradient After Tricuspid TEER Not Harmful at 1 Year: TriValve Registry Caitlin E. Cox March 21, 2023
News Conference News THT 2023 TEER or VAD/Transplant in the Advanced HF Patient With MR? Shelley Wood March 20, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023
News Conference News ACC 2023 CRP More Predictive of Future Events Than LDL in Statin-Treated Patients Caitlin E. Cox March 14, 2023
News Conference News ACC 2023 Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR Michael O'Riordan March 13, 2023
News Conference News ACC 2023 Real-world Primary MR TEER Outcomes Carry a Reminder: Do Better Shelley Wood March 10, 2023
News Conference News ACC 2023 STREAM-2: Half-Dose Tenecteplase Safe, Effective in Older STEMI Patients L.A. McKeown March 10, 2023
News Conference News ACC 2023 Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study Todd Neale March 10, 2023
News Conference News ACC 2023 MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis Michael O'Riordan March 10, 2023
News Conference News ACC 2023 ‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk Caitlin E. Cox March 10, 2023